Kaletra (80 mg + 20 mg) / ml oral solution
*Company:
AbbVie LimitedStatus:
No Recent UpdateLegal Category:
Product subject to restricted prescription (C)*Additional information is available within the SPC or upon request to the company

AbbVie Limited

Address:
Citywest Business Campus, Dublin 24, IrelandTelephone:
+353 1 428 7900Fax:
+353 1 428 7940